Biotest products are of prime ethical importance. They save lives and give new hope to the chronically ill.
Conscious of the responsibility this gives us, we direct our activities accordingly, in production as well as development, sales and raw materials procurement. Quality, user benefit, reliability and safety are our highest priorities. These are the conditions which ensure that we are able to fulfil our mission and, at the same time, they form the basis for the long-term sustainable development of our company.
Why are we developing another agent for the treatment of rheumatism, when so many other treatments are already available?
What is the advantage if one of our drugs can be administered differently?
Biotest’s products have one thing in common: there is an urgent need for them, and many are even considered indispensable. Their high ethical value is the basis for the sustainability of the company’s economic value.
We are concentrating on our strengths and aim to achieve income-oriented growth in each of our segments.
In a number of markets, Biotest is already the leading manufacturer or one of the major suppliers. We are working on further consolidating this position and expanding it – in the interests of patients, users, our partners and our employees.
And last but not least, for the benefit of our shareholders.
